Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-061621

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gad Soffer
Officer — EVP & Chief Strategy Officer
Period of report
Nov 15, 2017
Accepted (ET)
Nov 17, 2017 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 15, 2017M4,146$0.00A263,236D
Common StockNov 17, 2017S7,000$15.00D256,236D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Nov 15, 2017M4,146D——Common Stock4,1462,764D

Explanation of responses